Literature DB >> 1903629

Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.

T Gomi1, T Shiohara, T Munakata, K Imanishi, M Nagashima.   

Abstract

Although recent studies have suggested that a variety of cytokines released by keratinocytes and inflammatory leukocytes could contribute to induction or persistence of the inflammatory processes in psoriasis, it remains unclear how production of these cytokines is regulated in psoriatic patients. To elucidate the biologic relevance of these cytokines to the pathogenesis of psoriasis, we investigated serum levels of interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in 21 patients with psoriasis vulgaris, together with 21 healthy controls. The mean serum levels of interleukin 1 alpha and tumor necrosis factor alpha were not significantly different from those in controls, while those of interferon gamma were significantly elevated in the patients with psoriasis. Serum levels of interleukin 1 alpha correlated negatively with clinical disease severity expressed as psoriasis area and severity index score and with duration of psoriasis. In contrast, interferon gamma levels were related, although not significantly, to disease severity. In addition, an inverse correlation was noted between the interleukin 1 alpha levels and interferon gamma levels. These results indicate that interleukin 1 alpha and interferon gamma may be relevant to the induction and perpetuation, respectively, of the inflammatory responses in psoriasis, and that these cytokines, which have similar biologic properties, may strictly regulate one another's production in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903629

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis.

Authors:  K N Ekdahl; G Michaëlsson; B Gerdén; L Lööf; B Nilsson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium.

Authors:  H M Ockenfels; S N Wagner; C Keim-Maas; R Funk; G Nussbaum; M Goos
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

4.  Effects of the 24 N-terminal amino acids of p55PIK on endotoxinstimulated release of inflammatory cytokines by HaCaT cells.

Authors:  Feng Lv; Wei You; Yang Yu; Jun-Bo Hu; Bin Zhang; Jing Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

5.  Impact of lithium alone and in combination with antidepressants on cytokine production in vitro.

Authors:  Charlotte Petersein; Ulrich Sack; Roland Mergl; Jeremias Schönherr; Frank M Schmidt; Nicole Lichtblau; Kenneth C Kirkby; Katrin Bauer; Hubertus Himmerich
Journal:  J Neural Transm (Vienna)       Date:  2014-11-07       Impact factor: 3.575

6.  Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.

Authors:  M Kristensen; C Q Chu; D J Eedy; M Feldmann; F M Brennan; S M Breathnach
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5.

Authors:  M Kotb; H Ohnishi; G Majumdar; S Hackett; A Bryant; G Higgins; D Stevens
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.

Authors:  K Paukkonen; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.

Authors:  Daniela Bruch-Gerharz; Oliver Schnorr; Christoph Suschek; Karl-Friedrich Beck; Josef Pfeilschifter; Thomas Ruzicka; Victoria Kolb-Bachofen
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 10.  Pathogenic mechanisms shared between psoriasis and cardiovascular disease.

Authors:  Ramin Ghazizadeh; Hajime Shimizu; Mamiko Tosa; Mohammad Ghazizadeh
Journal:  Int J Med Sci       Date:  2010-08-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.